Chime Biologics Appoints Vice President of Manufacturing and Head of US Business Center

Talent is the core driving force behind Chime Biologics’ steady growth. Chime Biologics has a strong management team with extensive international knowledge and experience in biopharmaceutical industry, including R&D, process development, tech-transfer and scale-up, quality control, commercialization and international registration of biologics.

Vice President of Manufacturing with deep U.S. Manufacturing Management Experience

Thomas Matthew Risko

Vice President of Manufacturing

Thomas has over 35 years of manufacturing experience, including 25 years in biotechnology industry, in the production of therapeutic proteins, antibodies, and vaccines in the United States.  He is a manufacturing leader with experience in the production of several commercial blockbuster biologics and numerous clinical therapeutics. Previously Thomas held leadership, technical and commercial positions in Amgen Rhode Island, Regeneron Pharmaceuticals and Bio-Rad Laboratories.

Thomas received his bachelor’s degree in Biological Sciences from the State University of New York at Albany.

Head of U.S. Business Center

Walter Tian

Head of U.S. Business Center

 In April 2023, following the establishment of the European Business Center in Germany, Chime Biologics further accelerated its global expansion by establishing the U.S. Business Center in California, assuming leadership position for company CDMO U.S. business by Walter Tian.

Walter Tian is an industry veteran with well over 30 years of track record in life science and biopharmaceutical CRDMO industries. In his earlier career he worked in sales and marketing capacity for some well known US and international life science companies including PerkimElmer, Qiagen and OriGene. Over the last 12 years, he held key corporate marketing and business development positions in both CRO companies (DNA2.0/Atum, LakePharma) and CDMO companies (LakePharma and Curia). His impressive network in drug research and development in North America is critical to Chime’s global mission.

Walter received his bachelor degree in medicine at Xi’an Medical School and MS degree in immunology at Beijing Medical University. He also has an MBA certificate from Northeastern University in Boston, MA.

About CHIME BIOLOGICS

Chime Biologics is a leading CDMO with the world’s first modular biopharmaceutical factory, KUBio. It empowers the entire biologics processes – from cell line development to commercial manufacturing. Chime Biologics provides one-stop CMC solutions to worldwide biomedical customers, relying on cell line development and advanced technology development from its Shanghai Innovation Center and proven success in IND-enabling through BLA filing at its Wuhan campus. We share a common goal to make cutting-edge biologics affordable and accessible to all patients globally, fulfilling its commitment to human health.